- Author:
Seung Han LEE
1
;
Myeong Kyu KIM
;
Man Seok PARK
;
Seong Min CHOI
;
Joon Tae KIM
;
Byeong Chae KIM
;
Ki Hyun CHO
Author Information
- Publication Type:Original Article
- Keywords: Fibrinogen; Polymorphism; Stroke
- MeSH: Alleles; Atherosclerosis; Fibrinogen; Genotype; Humans; Plasma; Polymerase Chain Reaction; Risk Factors; Sequence Analysis, DNA; Stroke
- From:Journal of Clinical Neurology 2008;4(1):17-22
- CountryRepublic of Korea
- Language:English
- Abstract: Background and Purpose: We investigated the relationship between the beta-fibrinogen gene (FGB) -455 G/A polymorphism and plasma fibrinogen levels in Korean ischemic stroke patients. We also determined whether the frequency of the -455 G/A polymorphism differed between two subtypes of noncardioembolic stroke: large-artery atherosclerosis (LAA) and small-vessel occlusion (SVO). Methods: A total of 267 patients with noncardioembolic stroke were enrolled. Plasma fibrinogen and other risk factors for stroke were evaluated. FGB -455 G/A genotypes were determined by polymerase chain reaction with restrictive enzyme Hae III and automatic DNA sequencing. Results: The FGB -455 G/A polymorphism was significantly associated with an elevated plasma fibrinogen level (p<0.001). The frequency of the A allele in Korean stroke patients was 16.7%. However, the frequency of the -455 G/A polymorphism did not differ between LAA and SVO. Conclusions: The plasma fibrinogen level might be affected by the -455 G/A polymorphism in noncardioembolic stroke patients. However, the LAA and SVO subtypes of ischemic stroke were not affected by the -455 G/A polymorphism.